Skip to main content

Sjögren's syndrome

Thomas Dörner

  1. The difficulty in predicting the consequences of interactions between different cytokine networks has increased with the expansion of the T helper (Th) cell universe and the discovery of numerous B lymphocyte-...

    Authors: Pierre Youinou and Jacques-Olivier Pers
    Citation: Arthritis Research & Therapy 2011 13:227
  2. Sjögren's syndrome (SS), a systemic autoimmune disease, is characterized by inflammation of exocrine tissues accompanied by a significant loss of their secretory function. Clinical symptoms develop late and th...

    Authors: Nicolas Delaleu, Cuong Q Nguyen, Ammon B Peck and Roland Jonsson
    Citation: Arthritis Research & Therapy 2011 13:217
  3. Previously, a dominant role of the adaptive immune system in the pathogenesis of Sjögren's syndrome was suspected. Recent advances, however, have revealed a major role of the type I IFN pathway, documented by ...

    Authors: Hui Zhi Low and Torsten Witte
    Citation: Arthritis Research & Therapy 2011 13:218
  4. Circumstantial evidence suggests that retroviruses play a role in the pathogenesis of Sjögren's syndrome. Such evidence, derived from studies of patients with Sjögren's syndrome, includes the following: the pr...

    Authors: Nikolaos V Sipsas, Maria N Gamaletsou and Haralampos M Moutsopoulos
    Citation: Arthritis Research & Therapy 2011 13:212
  5. In vitro and in vivo experimental data have pointed to new immunopathogenic mechanisms in primary Sjögren's syndrome (pSS). The availability of targeted treatment modalities has opened new ways to selectively tar...

    Authors: Cees GM Kallenberg, Arjan Vissink, Frans GM Kroese, Wayel H Abdulahad and Hendrika Bootsma
    Citation: Arthritis Research & Therapy 2011 13:205